Transcatheter Aortic Valve Replacement (TAVR) research hub

Prospective, Long-term Evaluation of the SAPIEN 3 Ultra RESILIA Valve

This study looks at how well a new heart valve, called SAPIEN 3 Ultra RESILIA, works in patients with heart valve problems. Researchers will follow patients for up to 10 years to see how the valve performs and affects their health.